4Delemos JA, Blazing MA, Wviott SD, et al. Early intensive vs. delayed conservative simvastatin strategy in patients with acute coro- nary syndromes. Phase Z of the A to Z trial [ J ]. JAMA, 2004, 292 (11): 1307-1316.
5Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus mod- erate vipid vowering with statins after acute coronary syndromes [ J]. N Engl J Med, 2004, 350 (15) : 1495 -1504.
6LaRosa JC, Grundy SM, Waters DD, et al. Intensive Lipid Lowering with atorvastatin in patients with stable coronary disease [ J ]. N Eng J Med, 2005, 352 (14) : 1425 -1435.
7Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of car- diovascular disease with pravastatin in Japan ( MEGA study) : a pro- spective randomized controlled trial [ J ]. Lancet, 2006, 368 (9542) : 1155 -1163.
9Charatan F. Bayer decides to withdraw cholesterol lowering drug [ J ]. BMJ, 2001, 323 (7309): 359.
10Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident di- abetes: a collaborative meta - analysis of randomized statin trials [ J ]. Lancet, 2010, 375 (9716): 735-742.
